Skip To Main Content
Kaiying Wang on Muck Rack

Kaiying Wang

As seen in: Nature, Wiley Online Library, MDPI, Virology Journal, Royal Society of Chemistry, Law360, Dove Medical Press, JD Supra, Lexology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kaiying

Contact Kaiying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and efficacy of rectal spacers in locally advanced prostate cancer

|
By Kaiying Wang, Chen’en Ye, Arshvin Kesavan, Ziting Wang, Edmund Chiong, Woon Chau Tsang, Kiat Huat Ooi
| Nature Verified
Abstract Biodegradable perirectal spacers reduce rectal irradiation and rectal toxicity during radiotherapy for prostate cancer (PCa). However, while their use is well-established in localised PCa, there is minimal data on locally advanced PCa. Objective: to determine safety and efficacy of rectal spacers in patients with cT3 disease. A prospective single-centre cohort study was conducted from 2022 to 2024.
Open in Who Shared Issue with article?

From Devices to Systems: Integration Strategies for Micro-Supercapacitors in Microsystems

|
By Zhuohao Liu, Kaiying Wang
| Wiley Online Library Verified
1 Introduction The rapid advancement of micro/nanoelectromechanical systems (MEMS/NEMS), wearable electronics, implantable medical devices, and Internet of Things (IoT) platforms has created an increasing demand for compact, reliable, and efficient micro power sources [1-4].
Open in Who Shared Issue with article?

AI- and Cryptocurrency-Related Securities Class Action Filings in 2025 H1 | JD Supra

|
By H. Gregory Baker, Kaiying Wang
| JD Supra
Cornerstone Research recently published its 2025 midyear assessment of securities class action filings.[1] Compared to the second half of 2024, securities class action filings in the first half of 2025 decreased slightly from 115 to 114 filings. However, notably, the numbers of Artificial Intelligence (AI)- and cryptocurrency-related filings increased significantly when compared against the second half of 2024.
Open in Who Shared Issue with article?
See all 29 articles